An engineering professor has received financial support from Susan G. Komen for breast cancer research.
His project is among 60 grants totaling $26 million awarded to researchers nationwide. Those initiatives are focused on improving outcomes for metastatic breast cancer, reducing disparities in survivorship and developing new, more effective treatments.
John T. Wilson, assistant professor of chemical and biomolecular engineering and biomedical engineering and a Vanderbilt-Ingram Cancer Center investigator, will receive $449,616 to support his initiative “STINGing Cancer with Nanoparticles to Enhance Immunotherapy.”
His overall goal is to leverage nanotechnology and molecular engineering approaches to develop new immunotherapeutic modalities for treating metastatic breast cancer.
“Breast cancer does not affect everyone equally and with the grants we’re funding this year, we’re moving closer to new therapies for aggressive forms of cancer, understanding why treatment doesn’t work in some patients and making sure everyone has access to the care they need,” said Paula Schneider, chief executive officer of Susan G. Komen.
Full article: Here